AKT1 and myotonic dystrophy type 1: Different pathways have been described that contribute to muscle atrophy in DM1, such as AKT-GSK3β [7, 8], TWEAK/Fn14 [9], AMPK/mTORC1 [10, 11], and PKC [12, 13].